Navigation ▼

Therapieoptimierung aggressiver Non-Hodgkin-Lymphome durch modifizierte anti-CD20-Antikörper: Präklinische Evaluation von GA101

Files in this item

The following license files are associated with this item:


Abstract



This item appears in the following Collection(s)